Home>People>Doctoral Candidates

Burak Muhammed Demircan

Turkey
LGSA Member

Analysis of the Functional Roles of NADPH oxidase 4 (NOX4) in Normal Hematopoiesis and Myeloid Malignancies

Friedrich Schiller University Jena (FSU) - Faculty of Medicine
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI): Heidel Cooperation Group (UKJ)

First Supervisor:

Florian Heidel (Leibniz Institute on Aging - Fritz Lipmann Institute (FLI))

Co – Supervisor(s):

Aria Baniahmad (Jena University Hospital (UKJ))

Doctoral Disputation:

2022

Publications 2022:

  • Analysis of the functional roles of NADPH oxidase 4 (NOX4) in normal hematopoiesis and myeloid malignancies
    Demircan MB
    Dissertation 2022, Jena, Germany
  • Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia Cells.
    Demircan MB, Mgbecheta PC, Kresinsky A, Schnoeder TM, Schröder K, Heidel FH, Böhmer FD
    Antioxidants (Basel) 2022, 11(3)
  • Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).
    Demircan MB, Schnoeder TM, Mgbecheta PC, Schröder K, Böhmer FD, Heidel FH
    J Cancer Res Clin Oncol 2022, 148(8), 1983-90

Publications 2020:

  • Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.
    Demircan* MB, Tohumeken* S, Gunduz N, Khalily MA, Tekinay T, Guler MO, Tekinay AB
    Biotechnol J 2020, 15(12), e2000100 * equal contribution